Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - abamectin; closantel; levamisole hydrochloride; albendazole - oral solution/suspension - abamectin anthelmintic active 1.0 g/l; closantel anthelmintic active 37.5 g/l; levamisole hydrochloride anthelmintic active 40.0 g/l; albendazole carbamate-benzimidazole active 25.0 g/l - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm (also inhibited l4) | black scour worm - trichostrongylus spp. | hookworm - bunostomum spp. | intestinal threadworm - s. papillosus | large bowel worm - o. venulosum | large mouthed bowel worm | large stomach worm | liver fluke - mature and immature | lungworm - dictyocaulus viviparus | nasal bot | nodule worm - o. columbianum | o. circumcincta - including inhibited l4 | sheep itch mite | small intestinal worm - cooperia spp. | stomach hair worm | tapeworm (moniezia spp.) - head/segments | thin necked intestinal worm | whipworm - trichuris ovis | barber's pole worm | large lungworm | liver fluke-6 week old stages | psorobia ovis | sheep nasal bot fly | small brown stomach worms | teladorsagia circumcincta | trichostrongylus colubriformis | trichostrongylus vitrinus

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - albendazole; abamectin; levamisole hydrochloride; closantel - albendazole 25 g/litre; abamectin 1 g/litre; levamisole hydrochloride 40 g/litre; closantel 37.5 g/litre - endoparasiticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - copper disodium ehtylene diamine tetratacetate; zinc disodium ethylenediamine tetraacetate; cobalt disodium ethylenediamine tetraacetate; abamectin; closantel; levamisole hydrochloride; albendazole; iodine as ethylene diamine dihydroiodide; selenium as sodium selenate - oral solution/suspension - copper disodium ehtylene diamine tetratacetate ungrouped active 2.1 g/l; zinc disodium ethylenediamine tetraacetate ungrouped active 0.6 g/l; cobalt disodium ethylenediamine tetraacetate ungrouped active 0.2 g/l; abamectin anthelmintic active 1.0 g/l; closantel anthelmintic active 37.5 g/l; levamisole hydrochloride anthelmintic active 40.0 g/l; albendazole carbamate-benzimidazole active 25.0 g/l; iodine as ethylene diamine dihydroiodide mineral-iodine active 1.0 g/l; selenium as sodium selenate mineral-selenium active 0.5 g/l - parasiticides

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - selenium present as sodium selenate; iodine present as ethylenediamine dihydroiodide; levamisole hydrochloride; abamectin; albendazole; cobalt present as cobalt edta; copper present as copper edta; zinc present as zinc edta; closantel - selenium present as sodium selenate 0.5 g/litre; iodine present as ethylenediamine dihydroiodide 1 g/litre; levamisole hydrochloride 40 g/litre; abamectin 1 g/litre; albendazole 25 g/litre; cobalt present as cobalt edta 0.2 g/litre; copper present as copper edta 2.1 g/litre; zinc present as zinc edta 0.6 g/litre; closantel 37.5 g/litre - ectoparasiticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - abamectin; closantel; levamisole hydrochloride; albendazole - oral solution/suspension - abamectin anthelmintic active 1.0 g/l; closantel anthelmintic active 37.5 g/l; levamisole hydrochloride anthelmintic active 40.0 g/l; albendazole carbamate-benzimidazole active 25.0 g/l - parasiticides

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - peginterferon alfa-2b 100ug; ribavirin 200mg;   - combination - 200mg+100µg(clearclick) - active: peginterferon alfa-2b 100ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection active: ribavirin 200mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide - pegatron combination therapy is indicated for the treatment of na?ve, relapse and non-responder patients with chronic hepatitis c (see clinical trials). patients must be 18 years of age or older and have compensated liver disease. pegatron combination therapy is also indicated for the treatment of patients with chronic hepatitis c who are co-infected with clinically stable hiv. interferon alfa monotherapy (including peg-intron) is indicated mainly in case of intolerance or contraindication to ribavirin. rebetol capsules must not be used alone because ribavirin is not effective as monotherapy in the treatment of hepatitis c. pegatron combination therapy is indicated for the treatment of chronic hepatitis c in children and adolescents with a bodyweight of nlt 27 kg with compensated liver disease and who have not received previous interferon treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - peginterferon alfa-2b 120ug; ribavirin 200mg;   - combination - 200mg+120µg(clearclick) - active: peginterferon alfa-2b 120ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection active: ribavirin 200mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide - pegatron combination therapy is indicated for the treatment of na?ve, relapse and non-responder patients with chronic hepatitis c (see clinical trials). patients must be 18 years of age or older and have compensated liver disease. pegatron combination therapy is also indicated for the treatment of patients with chronic hepatitis c who are co-infected with clinically stable hiv. interferon alfa monotherapy (including peg-intron) is indicated mainly in case of intolerance or contraindication to ribavirin. rebetol capsules must not be used alone because ribavirin is not effective as monotherapy in the treatment of hepatitis c. pegatron combination therapy is indicated for the treatment of chronic hepatitis c in children and adolescents with a bodyweight of nlt 27 kg with compensated liver disease and who have not received previous interferon treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - peginterferon alfa-2b 150ug; ribavirin 200mg;   - combination - 200mg+150µg(clearclick) - active: peginterferon alfa-2b 150ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection active: ribavirin 200mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide - pegatron combination therapy is indicated for the treatment of na?ve, relapse and non-responder patients with chronic hepatitis c (see clinical trials). patients must be 18 years of age or older and have compensated liver disease. pegatron combination therapy is also indicated for the treatment of patients with chronic hepatitis c who are co-infected with clinically stable hiv. interferon alfa monotherapy (including peg-intron) is indicated mainly in case of intolerance or contraindication to ribavirin. rebetol capsules must not be used alone because ribavirin is not effective as monotherapy in the treatment of hepatitis c. pegatron combination therapy is indicated for the treatment of chronic hepatitis c in children and adolescents with a bodyweight of nlt 27 kg with compensated liver disease and who have not received previous interferon treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - peginterferon alfa-2b 50ug; ribavirin 200mg;   - combination - 200mg+50µg (clearclick) - active: peginterferon alfa-2b 50ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection active: ribavirin 200mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide - pegatron combination therapy is indicated for the treatment of na?ve, relapse and non-responder patients with chronic hepatitis c (see clinical trials). patients must be 18 years of age or older and have compensated liver disease. pegatron combination therapy is also indicated for the treatment of patients with chronic hepatitis c who are co-infected with clinically stable hiv. interferon alfa monotherapy (including peg-intron) is indicated mainly in case of intolerance or contraindication to ribavirin. rebetol capsules must not be used alone because ribavirin is not effective as monotherapy in the treatment of hepatitis c. pegatron combination therapy is indicated for the treatment of chronic hepatitis c in children and adolescents with a bodyweight of nlt 27 kg with compensated liver disease and who have not received previous interferon treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - peginterferon alfa-2b 80ug; ribavirin 200mg;   - combination - 200mg+80µg(clearclick) - active: peginterferon alfa-2b 80ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection active: ribavirin 200mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide - pegatron combination therapy is indicated for the treatment of na?ve, relapse and non-responder patients with chronic hepatitis c (see clinical trials). patients must be 18 years of age or older and have compensated liver disease. pegatron combination therapy is also indicated for the treatment of patients with chronic hepatitis c who are co-infected with clinically stable hiv. interferon alfa monotherapy (including peg-intron) is indicated mainly in case of intolerance or contraindication to ribavirin. rebetol capsules must not be used alone because ribavirin is not effective as monotherapy in the treatment of hepatitis c. pegatron combination therapy is indicated for the treatment of chronic hepatitis c in children and adolescents with a bodyweight of nlt 27 kg with compensated liver disease and who have not received previous interferon treatment.